KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Current Assets (2016 - 2025)

Astrazeneca has reported Current Assets over the past 11 years, most recently at $28.7 billion for Q4 2025.

  • Quarterly results put Current Assets at $28.7 billion for Q4 2025, up 11.21% from a year ago — trailing twelve months through Dec 2025 was $28.7 billion (up 11.21% YoY), and the annual figure for FY2025 was $28.7 billion, up 11.21%.
  • Current Assets for Q4 2025 was $28.7 billion at Astrazeneca, up from $25.8 billion in the prior quarter.
  • Over the last five years, Current Assets for AZN hit a ceiling of $28.7 billion in Q4 2025 and a floor of $22.6 billion in Q4 2022.
  • Median Current Assets over the past 5 years was $25.8 billion (2024), compared with a mean of $25.7 billion.
  • Biggest five-year swings in Current Assets: soared 34.28% in 2021 and later decreased 13.91% in 2022.
  • Astrazeneca's Current Assets stood at $26.2 billion in 2021, then fell by 13.91% to $22.6 billion in 2022, then increased by 10.89% to $25.1 billion in 2023, then increased by 3.09% to $25.8 billion in 2024, then increased by 11.21% to $28.7 billion in 2025.
  • The last three reported values for Current Assets were $28.7 billion (Q4 2025), $25.8 billion (Q4 2024), and $25.1 billion (Q4 2023) per Business Quant data.